Dance and Diabetes/Prediabetes Self-Management

October 26, 2021 updated by: Wake Forest University Health Sciences

Dance as an Intervention to Improve Diabetes and Prediabetes Self-Management

The Dance for Diabetes program was designed as a community service project for the North Carolina Albert Schweitzer Fellowship. The purpose of this research is to evaluate the effectiveness of the project and its impact on participants. This study will assess whether a group dance workshop along with diabetes education can help people with diabetes and prediabetes.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a pilot study that will be testing whether or not a group dance workshop is useful and effective. If it is, the study team will refine the workshop model and do additional dance classes in the future. This research study will involve attending a dance workshop once a week for 2 months using an online, video-conferencing computer application. Participants will also receive information about exercise and how to manage their diabetes. Participants will receive a phone call every week during the 2 months to assess their experience. Study participants will also be asked to complete surveys at the beginning and end of the 2-month session, as well as 1 month and 2 months after the classes end.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Winston-Salem, North Carolina, United States, 27157
        • Wake Forest Baptist Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adults proficient in English with diabetes or prediabetes
  • subjects who have an established healthcare provider

Exclusion Criteria:

  • known cardiovascular disease (acute coronary syndrome, stable or unstable angina, coronary or other arterial revascularization, stroke, transient ischemic attack, and peripheral arterial disease) for the last 6 months
  • unwilling or unable to partake in light to moderate level of dance physical activity for 1 hour because of physical impairment (e.g. wheelchair, amputation)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group
All participants will attend a 2-month weekly light-to-moderate intensity dance workshop followed by a brief diabetes education and discussion session.
Participants will attend a 2-month weekly light-to-moderate intensity dance workshop.
The dance classes will be followed by a brief diabetes education and discussion session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
National Health and Nutrition Examination Survey Physical Activity and Physical Fitness Questionnaire (NHANES 2019-2020 PAQ)--Activity Confirmation
Time Frame: baseline
Percentage of subjects who confirm that they are physically active in questionnaire
baseline
NHANES 2019-2020 PAQ--Days Active
Time Frame: baseline
Average number of days subjects report being active
baseline
NHANES 2019-2020 PAQ--minutes active
Time Frame: baseline
Average number of minutes (10-60) per day that participants engage in activity
baseline
NHANES 2019-2020 PAQ--Activity Confirmation
Time Frame: 4 weeks post intervention completion
Percentage of subjects who confirm that they are physically active in questionnaire
4 weeks post intervention completion
NHANES 2019-2020 PAQ--Days Active
Time Frame: 4 weeks post intervention completion
Average number of days subjects report being active
4 weeks post intervention completion
NHANES 2019-2020 PAQ--minutes active
Time Frame: 4 weeks post intervention completion
Average number of minutes (10-60) per day that participants engage in activity
4 weeks post intervention completion
NHANES 2019-2020 PAQ--Activity Confirmation
Time Frame: 8 weeks post baseline
Percentage of subjects who confirm that they are physically active in questionnaire
8 weeks post baseline
NHANES 2019-2020 PAQ--Days Active
Time Frame: 8 weeks post baseline
Average number of days subjects report being active
8 weeks post baseline
NHANES 2019-2020 PAQ--minutes active
Time Frame: 8 weeks post baseline
Average number of minutes (10-60) per day that participants engage in activity
8 weeks post baseline
NHANES 2019-2020 PAQ--Activity Confirmation
Time Frame: 8 weeks post intervention completion
Percentage of subjects who confirm that they are physically active in questionnaire
8 weeks post intervention completion
NHANES 2019-2020 PAQ--Days Active
Time Frame: 8 weeks post intervention completion
Average number of days subjects report being active
8 weeks post intervention completion
NHANES 2019-2020 PAQ--minutes active
Time Frame: 8 weeks post intervention completion
Average number of minutes (10-60) per day that participants engage in activity
8 weeks post intervention completion
Diabetes Empowerment Scale (DES) score
Time Frame: baseline
Score ranges from 1 to 5, with 1 denoting a worse outcome.
baseline
DES Score
Time Frame: 4 weeks post intervention completion
This questionnaire is given to determine if there were any changes in participants' activity level 4 weeks post intervention. Score ranges from 1 to 5, with 1 denoting a worse outcome.
4 weeks post intervention completion
DES score
Time Frame: 8 weeks post baseline
This questionnaire is given 8 weeks post baseline in order to determine any improvements made during the intervention. Score ranges from 1 to 5, with 1 denoting a worse outcome.
8 weeks post baseline
DES Score
Time Frame: 8 weeks post intervention completion
This questionnaire is given to determine if there were any changes in participants' activity level 8 weeks post intervention. Score ranges from 1 to 5, with 1 denoting a worse outcome.
8 weeks post intervention completion

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: 8 weeks post intervention completion
measured in kilograms
8 weeks post intervention completion
Body Mass Index (BMI)
Time Frame: 8 weeks post intervention completion
Weight in kilograms divided by the square of height in meters. A high BMI can be an indicator of high body fatness.
8 weeks post intervention completion
Glycated Hemoglobin (A1c)
Time Frame: 8 weeks post intervention completion
The A1c test is a blood test that provides information about average levels of blood glucose over the past 3 months. The A1c test can be used to diagnose type 2 diabetes and prediabetes. The A1c test result is reported as a percentage. The higher the percentage, the higher the blood glucose levels have been. A normal A1c level is below 5.7 percent
8 weeks post intervention completion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Julienne Kirk, PharmD, Wake Forest University Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 3, 2020

Primary Completion (Actual)

May 3, 2021

Study Completion (Actual)

May 3, 2021

Study Registration Dates

First Submitted

June 8, 2020

First Submitted That Met QC Criteria

June 10, 2020

First Posted (Actual)

June 11, 2020

Study Record Updates

Last Update Posted (Actual)

November 3, 2021

Last Update Submitted That Met QC Criteria

October 26, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

All of the individual participant data collected during the trial will be available after deidentification.

IPD Sharing Time Frame

All data will be available immediately following publication without end date.

IPD Sharing Access Criteria

Information will be available to anyone who wishes to access the data for any purpose.

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)
  • Clinical Study Report (CSR)
  • Analytic Code

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes

Clinical Trials on dance

3
Subscribe